US Stock MarketDetailed Quotes

MRKR Marker Therapeutics

Watchlist
  • 4.1002
  • -0.2098-4.87%
Close Apr 18 16:00 ET
  • 4.0000
  • -0.1002-2.44%
Post 16:32 ET
36.50MMarket Cap-4361P/E (TTM)

Marker Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
3.5M
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--3.5M
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-26.32%14.58M
-3.32%2.94M
-45.08%3.2M
-21.53%4.13M
-12.69%8.55M
-49.87%19.79M
-68.88%3.04M
-41.87%5.83M
-51.71%5.27M
11.54%9.79M
Selling and administrative expenses
-34.05%7.48M
-14.76%1.38M
-56.32%1.41M
-19.66%2.52M
-32.61%2.52M
-12.29%11.34M
-45.94%1.62M
-0.15%3.23M
-11.91%3.14M
18.96%3.73M
-General and administrative expense
-34.05%7.48M
-14.76%1.38M
-56.32%1.41M
-19.66%2.52M
-32.61%2.52M
-12.29%11.34M
-45.94%1.62M
-0.15%3.23M
-11.91%3.14M
18.96%3.73M
Research and development costs
-12.96%10.42M
19.93%2.62M
-43.07%2.04M
-18.67%2.38M
3.48%7.27M
-56.94%11.97M
-72.78%2.18M
-47.06%3.59M
-60.22%2.92M
24.51%7.03M
Other operating expenses
5.76%-3.31M
-39.17%-1.06M
74.23%-257.61K
3.52%-762.66K
-28.00%-1.23M
-182.96%-3.51M
---759.14K
---999.57K
---790.51K
---964.32K
Operating profit
26.32%-14.58M
3.32%-2.94M
45.08%-3.2M
21.53%-4.13M
48.42%-5.05M
49.87%-19.79M
68.88%-3.04M
41.87%-5.83M
51.71%-5.27M
-11.54%-9.79M
Net non-operating interest income expense
117.35%539.16K
84.02%201.34K
118.63%218.09K
-1.97%35.08K
2,615.88%84.65K
4,251.98%248.06K
11,191.02%109.41K
12,510.62%99.75K
1,389.22%35.79K
102.80%3.12K
Non-operating interest income
117.35%539.16K
84.02%201.34K
118.63%218.09K
-1.97%35.08K
2,615.88%84.65K
4,251.98%248.06K
11,191.02%109.41K
12,510.62%99.75K
1,389.22%35.79K
102.80%3.12K
Other net income (expense)
90.32%-232.97K
-114.09K
-118.88K
Special income (charges)
----
----
----
----
--0
----
----
----
----
---118.88K
-Less:Other special charges
----
----
----
----
----
----
----
----
----
--118.88K
Other non- operating income (expenses)
----
----
----
----
----
90.32%-232.97K
---114.09K
----
----
----
Income before tax
28.99%-14.04M
10.08%-2.74M
47.93%-2.98M
21.67%-4.1M
49.88%-4.97M
52.78%-19.78M
68.83%-3.04M
53.93%-5.73M
52.02%-5.23M
-12.88%-9.91M
Income tax
3.68K
0
Net income
72.48%-8.24M
27.31%-2.8M
56.91%-2.98M
127.21%2.52M
49.88%-4.97M
28.53%-29.93M
60.50%-3.86M
44.33%-6.92M
15.24%-9.24M
-12.88%-9.91M
Net income continuous Operations
28.97%-14.05M
9.96%-2.74M
47.93%-2.98M
21.67%-4.1M
49.88%-4.97M
52.78%-19.78M
68.83%-3.04M
53.93%-5.73M
52.02%-5.23M
-12.88%-9.91M
Net income discontinuous operations
157.21%5.81M
92.26%-62.94K
--0
264.90%6.61M
----
---10.15M
---813.06K
---1.19M
---4.01M
----
Minority interest income
Net income attributable to the parent company
72.48%-8.24M
27.31%-2.8M
56.91%-2.98M
127.21%2.52M
49.88%-4.97M
28.53%-29.93M
60.50%-3.86M
44.33%-6.92M
15.24%-9.24M
-12.88%-9.91M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
72.48%-8.24M
27.31%-2.8M
56.91%-2.98M
127.21%2.52M
49.88%-4.97M
28.53%-29.93M
60.50%-3.86M
44.33%-6.92M
15.24%-9.24M
-12.88%-9.91M
Basic earnings per share
73.74%-0.94
28.89%-0.32
59.04%-0.34
126.13%0.29
52.10%-0.57
34.55%-3.58
61.54%-0.45
44.67%-0.83
14.62%-1.11
25.63%-1.19
Diluted earnings per share
73.74%-0.94
28.89%-0.32
59.04%-0.34
126.13%0.29
52.10%-0.57
34.55%-3.58
61.54%-0.45
44.67%-0.83
14.62%-1.11
25.63%-1.19
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 00003.5M00000
Operating revenue --0--0--0--0--3.5M--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -26.32%14.58M-3.32%2.94M-45.08%3.2M-21.53%4.13M-12.69%8.55M-49.87%19.79M-68.88%3.04M-41.87%5.83M-51.71%5.27M11.54%9.79M
Selling and administrative expenses -34.05%7.48M-14.76%1.38M-56.32%1.41M-19.66%2.52M-32.61%2.52M-12.29%11.34M-45.94%1.62M-0.15%3.23M-11.91%3.14M18.96%3.73M
-General and administrative expense -34.05%7.48M-14.76%1.38M-56.32%1.41M-19.66%2.52M-32.61%2.52M-12.29%11.34M-45.94%1.62M-0.15%3.23M-11.91%3.14M18.96%3.73M
Research and development costs -12.96%10.42M19.93%2.62M-43.07%2.04M-18.67%2.38M3.48%7.27M-56.94%11.97M-72.78%2.18M-47.06%3.59M-60.22%2.92M24.51%7.03M
Other operating expenses 5.76%-3.31M-39.17%-1.06M74.23%-257.61K3.52%-762.66K-28.00%-1.23M-182.96%-3.51M---759.14K---999.57K---790.51K---964.32K
Operating profit 26.32%-14.58M3.32%-2.94M45.08%-3.2M21.53%-4.13M48.42%-5.05M49.87%-19.79M68.88%-3.04M41.87%-5.83M51.71%-5.27M-11.54%-9.79M
Net non-operating interest income expense 117.35%539.16K84.02%201.34K118.63%218.09K-1.97%35.08K2,615.88%84.65K4,251.98%248.06K11,191.02%109.41K12,510.62%99.75K1,389.22%35.79K102.80%3.12K
Non-operating interest income 117.35%539.16K84.02%201.34K118.63%218.09K-1.97%35.08K2,615.88%84.65K4,251.98%248.06K11,191.02%109.41K12,510.62%99.75K1,389.22%35.79K102.80%3.12K
Other net income (expense) 90.32%-232.97K-114.09K-118.88K
Special income (charges) ------------------0-------------------118.88K
-Less:Other special charges --------------------------------------118.88K
Other non- operating income (expenses) --------------------90.32%-232.97K---114.09K------------
Income before tax 28.99%-14.04M10.08%-2.74M47.93%-2.98M21.67%-4.1M49.88%-4.97M52.78%-19.78M68.83%-3.04M53.93%-5.73M52.02%-5.23M-12.88%-9.91M
Income tax 3.68K0
Net income 72.48%-8.24M27.31%-2.8M56.91%-2.98M127.21%2.52M49.88%-4.97M28.53%-29.93M60.50%-3.86M44.33%-6.92M15.24%-9.24M-12.88%-9.91M
Net income continuous Operations 28.97%-14.05M9.96%-2.74M47.93%-2.98M21.67%-4.1M49.88%-4.97M52.78%-19.78M68.83%-3.04M53.93%-5.73M52.02%-5.23M-12.88%-9.91M
Net income discontinuous operations 157.21%5.81M92.26%-62.94K--0264.90%6.61M-------10.15M---813.06K---1.19M---4.01M----
Minority interest income
Net income attributable to the parent company 72.48%-8.24M27.31%-2.8M56.91%-2.98M127.21%2.52M49.88%-4.97M28.53%-29.93M60.50%-3.86M44.33%-6.92M15.24%-9.24M-12.88%-9.91M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 72.48%-8.24M27.31%-2.8M56.91%-2.98M127.21%2.52M49.88%-4.97M28.53%-29.93M60.50%-3.86M44.33%-6.92M15.24%-9.24M-12.88%-9.91M
Basic earnings per share 73.74%-0.9428.89%-0.3259.04%-0.34126.13%0.2952.10%-0.5734.55%-3.5861.54%-0.4544.67%-0.8314.62%-1.1125.63%-1.19
Diluted earnings per share 73.74%-0.9428.89%-0.3259.04%-0.34126.13%0.2952.10%-0.5734.55%-3.5861.54%-0.4544.67%-0.8314.62%-1.1125.63%-1.19
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg